Search for: "MERCK AND COMPANY, INCORPORATED" Results 41 - 54 of 54
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jun 2010, 2:55 pm by Tom Goldstein
Ideologues on both the left and right, as well as the public generally, frequently repeat their own received wisdoms that the Supreme Court is an easily categorized institution and that the Justices are committedly “liberal” or “conservative,” with Justice Kennedy as the lone swing vote. [read post]
14 Feb 2018, 2:57 pm by Kevin LaCroix
The petitioner/defendant in Kokesh was an investment advisor who provided advice to business-development companies. [read post]
2 Jul 2009, 5:18 am
The defendant tobacco company moved for summary judgment on the warning claim, which was denied. [read post]
12 Jul 2017, 3:50 am by Kevin LaCroix
A ransomware victim company’s files are rarely exfiltrated by a ransomware attacker, rather the attacker encrypts the files so a victim company cannot access them. [read post]
30 Nov 2022, 2:13 pm by Kevin LaCroix
Securities Litigation, the court rejected the defendants’ price impact challenge, explaining that “‘[w]hile it is generally true that in an efficient market, any information released to the public is presumed to be immediately digested and incorporated into the price of a security, it is plausible that complex economic data understandable only through expert analysis may not be readily digestible by the marketplace. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
27 Apr 2007, 12:04 pm
Amgen persuasively explained the position of his company in a scenario that is echoed by all major pioneer pharma and biotech entities and manifests the futility of any attempt to ram through Congress a one-size-fits-all "second" window solution. [read post]
23 May 2008, 1:03 am
– Discussion of Catherine Tremblay’s article on cost approach: (IP finance), US Congress cites free expression as reason ICANN must remain controlled by US government: (IP Justice), A new organisation around IP in your company? [read post]
31 Aug 2014, 12:49 pm
(Pix (c) Larry Catá Backer 2014) Since 2010, I have been posting on the development of a new course I have been developing for our first year law school students, "Elements of Law. [read post]
20 Feb 2009, 5:04 am
Remember, this is pediatric surgery, and very few companies sell either drugs or devices specifically intended and approved for use in children. [read post]
19 Jun 2011, 10:13 pm
Merck & Co., 254 F.3d 1031, 1035 (Fed. [read post]
25 May 2011, 11:46 pm
Therasense, now Abbott, got into a patent battle involving 5,820,551 and similar patents claiming "disposable blood glucose test strips for diabetes management. [read post]